Dr. Harald Hübner

Lehrstuhl für Pharmazeutische Chemie

Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors (2017) Maschauer S, Einsiedel J, Reich D, Hübner H, Gmeiner P, Wester HJ, Prante O, Notni J Journal article, Original article Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior (2017) Stößel A, Brox R, Purkayastha N, Hübner H, Hocke C, Prante O, Gmeiner P Journal article, Original article [18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ‑Opioid Receptor. (2017) Nebel N, Strauch B, Maschauer S, Lasch R, Rampp H, Fehler S, Bock L, et al. Journal article, Original article Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level (2016) Tabor A, Weisenburger S, Banerjee A, Purkayastha N, Kaindl J, Hübner H, Wei L, et al. Journal article, Original article Structure-based discovery of opioid analgesics with reduced side effects (2016) Manglik A, Lin H, Aryal DK, Mccorvy JD, Dengler D, Corder G, Levit A, et al. Journal article, Original article Dibenzo[b,f][1,4]oxazepines and dibenzo[b,e]oxepines: Influence of the chlorine substitution pattern on the pharmacology at the H1R, H4R, 5-HT2AR and other selected GPCRs. (2016) Naporra F, Gobleder S, Wittmann HJ, Spindler J, Bodensteiner M, Bernhardt G, Hübner H, et al. Journal article, Original article Structure-guided development of dual ß2 adrenergic/dopamine D-2 receptor agonists (2016) Weichert D, Stanek M, Hübner H, Gmeiner P Journal article, Original article Development of Covalent Ligand-Receptor Pairs to Study the Binding Properties of Nonpeptidic Neurotensin Receptor 1 Antagonists. (2016) Kling R, Plomer M, Lang C, Banerjee A, Hübner H, Gmeiner P Journal article, Original article Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples. (2016) Keller M, Kuhn KK, Einsiedel J, Hübner H, Biselli S, Mollereau C, Wifling D, et al. Journal article, Original article Structure-guided development of heterodimer-selective GPCR ligands (2016) Hübner H, Schellhorn T, Gienger M, Schaab C, Kaindl J, Leeb L, Clark T, et al. Journal article, Original article